COPD Therapeutics in Major Developed Markets Forecast to year 2021: 1 | Page 3

- Assess the safety and efficacy of current treatment options, with extensive product profiles on
prominent marketed therapies, and a heatmap directly comparing safety and efficacy data.
- Analyze the COPD pipeline and stratify by stage of development, molecule type, and molecular
target. The most promising late-stage therapies are profiled and assessed in terms of clinical
performance and competitiveness, alongside a single-product forecast.
- Predict growth in market size in eight major markets, with in-depth market forecasting from 2014 to
2021. The forecasts will provide an understanding of how epidemiology trends, new drug entries, and
patent expirations will influence market value.
- Identify commercial opportunities in the COPD deals landscape by analyzing trends in licensing
and co-development deals, and by profiling the most significant deals that have occurred in this
indication in recent years.
Ask for Discount at – http://www.absolutereports.com/enquiry/request-discount/10070564
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 9
2.1 Disease Introduction 9
2.2 Symptoms 9
2.3 Etiology 9
2.4 Pathophysiology 10
2.5 Diagnosis 10
2.6 Assessment of Disease Severity 11
2.7 Treatment 12
2.8 Treatment Algorithm 14
2.8.1 Mild COPD 14
2.8.2 Moderate-to-Severe COPD 15
2.8.3 Very Severe COPD 16
2.8.4 Marketed Products Heat Map 17
3 Marketed Products 21